梅西拉和奥西洛德罗斯塔特之间的不良事件概况差异:FDA不良事件报告系统的药监测研究
Chunyong Xia1, Lanxin Hu2, Ying Fan1
1Department of Pharmacy, Chongqing university jiangjin hospital, chongqing, China.
概括
这项研究比较了类固醇抑制剂osilodrostat和 metyrapone的不良事件 (AE). 奥西洛德罗斯塔特显示出意想不到的副作用,如低和高血压,而米他与呼吸道和肝脏问题有关.
科学领域:
- 药物监督 药物监督 药物监督
- 内分泌学 在内分泌学.
- 药品安全 药品安全
背景情况:
- 米特拉和奥西洛德罗斯塔特是11β-基酶抑制剂,用于治疗类固醇性疾病.
- 这两种药物之间缺乏全面的安全性分析和不良事件 (AE) 的比较.
- 了解药物特定的AE概况对于临床决策至关重要.
研究的目的:
- 通过分析它们相关的不良事件,比较奥西洛德罗斯塔特和米他的安全性.
- 识别和描述每个药物的意外不良事件信号.
- 根据患者的年龄和性别等人口统计数据调查AE发病率的潜在变化.
主要方法:
- 使用食品和药物管理局不良事件报告系统 (FAERS) 数据库来获取AE数据.
- 采用报告几率比率 (ROR) 方法来检测两种药物的显著AE信号.
- 使用医学监管活动词典 (MedDRA) 分类的AE系统器官类 (SOC).
主要成果:
- 奥西洛德洛斯塔特与意想不到的副作用有关,包括喘息,低血量,肌痛,高血压,腹部张张,丸激素升高,质炎和饥饿.
- 梅西拉与严重的副作用有关,如呼吸衰竭,深静脉血栓塞,间歇性肺病,肝功能异常和呼吸困扰.
- 人口分析揭示了特定的AE风险:接受奥西洛德罗斯塔特治疗的年轻人 (18-65岁) 容易患上上腺功能不充分,疲劳和心力衰竭;接受美西拉治疗的男性患上皮质激素升高,肌肉衰弱和急性呼吸窘迫综合征的风险更高.
结论:
- 奥西洛德罗斯塔特和米他具有明显的不良事件概况,需要仔细监测.
- 临床医生应警与每个药物相关的特定副作用,并考虑患者的年龄和性别.
- 建议进一步进行药监,以充分阐明这些类固醇抑制剂的安全性.
更多相关视频
07:36Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
1.6K
08:59An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
8.1K
相关概念视频
Pharmacovigilance
989
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
989
Drug Regulation
1.8K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.8K
Drug Administration and Therapy Phases: Overview
738
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
738
Opioid Analgesics: Synthetic and Semisynthetic Opioids
426
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
426
Analysis of Population Pharmacokinetic Data
382
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
382
Methods of Documentation II: POMR
1.1K
The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.
1.1K
